title: Long-term clinical experience with continuous ambulatory peritoneal dialysis: access-related problems.
abstract: Patients with end-stage renal failure can be treated with peritoneal dialysis, which is based on the capacity of the peritoneum to exchange fluid and metabolic products. To achieve this, dialysis fluid has to be instilled in the abdominal cavity through a permanent percutaneous access device. Apart from the advantages of peritoneal dialysis, severe problems are related to the access device. In this study, catheter-related morbidity and mortality are described, as found in the patient population from the University Hospital, Nijmegen, The Netherlands. The overall rates of exit-site infections and peritonitis are respectively 0.80 and 1.36 infection episodes per patient-year. Furthermore, it appeared that exit-site infections and peritonitis are the main reasons for discontinuation of dialysis and removal of the catheter. A correlation between the occurrence of peritonitis and exit-site infections was found. Also, the efficacy of the antibiotic treatment necessary to control these infectious complications is described. It is concluded that the design and the materials used to manufacture the currently used access device are the main reason for the existing morbidity in peritoneal dialysis. Therefore, more efforts should be undertaken to improve the access device, in which the design and the material used are critically considered.
authors.affiliation: Department of Oral Function, Laboratory of Biomaterials, Dental School, University of Nijmegen, The Netherlands.
authors.forename: Y C
authors.initials: YC
authors.lastname: Paquay
authors.forename: J A
authors.initials: JA
authors.lastname: Jansen
authors.forename: R J
authors.initials: RJ
authors.lastname: Goris
authors.forename: A J
authors.initials: AJ
authors.lastname: Hoitsma
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006297:Health Services Accessibility; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D009426:Netherlands; D010045:Outpatients; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology; D011446:Prospective Studies; D006435:Renal Dialysis; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents